| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | RFI EMERGENTES | 134,637348 | 22/04/2026 | 0,38% | · | ND |
| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | RFI EMERGENTES | 114,795875 | 22/04/2026 | 0,51% | · | ND |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | BIOTECNOLOGÍA | 122,340000 | 23/04/2026 | 4,17% | 27,85% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | BIOTECNOLOGÍA | 785,779032 | 23/04/2026 | 4,04% | 24,20% | ** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | BIOTECNOLOGÍA | 355,070977 | 23/04/2026 | 4,38% | 28,07% | *** |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | BIOTECNOLOGÍA | 115,888490 | 23/04/2026 | 4,44% | 28,85% | *** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | RVI CHINA | 85,840000 | 23/04/2026 | -3,80% | 4,38% | ** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI CHINA | 69,890000 | 23/04/2026 | -3,47% | 7,64% | ** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | RVI CHINA | 90,080000 | 23/04/2026 | -2,53% | 7,71% | ** |
| UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) P-ACC | RVI CHINA | 79,160000 | 23/04/2026 | -2,88% | 3,94% | * |
